Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

24

Revenue 2017

Daiichi Sankyo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.

Daiichi Sankyo

Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands

Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands She has also served in various positions for Daiichi Sankyo, Novartis, Eli Lilly and GlaxoSmithKline.

Vernalis accepts £33m takeover offer from Ligand Pharma

Vernalis accepts £33m takeover offer from Ligand Pharma If the deal goes through, Ligand will inherit a portfolio of more than eight fully-funded partnered programmes focused around central nervous system, oncology and inflammation, including collaborations with Servier, Daiichi ... Sankyo, Lundbeck, Asahi

Daiichi gets breakthrough status for pre-NDA leukaemia drug

Daiichi gets breakthrough status for pre-NDA leukaemia drug Quizartinib could have an advantage over rival drug Rydapt. Daiichi Sankyo is gearing up to file its acute myeloid leukaemia (AML) treatment quizartinib in the US, and could now get a ... After a year, survival was 26% with Daiichi Sankyo’s drug and 20%

Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more

Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more Meanwhile Daiichi Sankyo is now gearing up to file its acute myeloid leukaemia (AML) treatment quizartinib after it showed extended survival in a phase 3 trial of patients with FLT2-ITD

Abeona Therapeutics appoints new additions to board of directors

Abeona Therapeutics appoints new additions to board of directors Van Duyne, on the other hand, has previously held executive-level business development positions, which led him to serve as global head of business development for Daiichi Sankyo.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...
Generating data on long-term outcomes with gene and other advanced therapies
Gene therapy and advanced cell-based therapies offer patients hope and the potential to make them ‘chronically well’....

Infographics